资产负债表（Guardion Health Sciences Inc）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 截止日期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 流动资产： | ||||||||
| 现金及现金等价物(元) | 6,359,646.00 | 7,657,309.00 | 8,365,987.00 | 8,774,626.00 | 10,655,490.00 | 12,946,003.00 | 4,224,551.00 | 4,832,469.00 |
| 受限制存款及现金流动(元) | - | - | - | - | 5,250,000.00 | - | - | - |
| 应收账款及票据(元) | 2,274,394.00 | 1,766,028.00 | 1,555,141.00 | 1,946,746.00 | 1,924,353.00 | 1,873,743.00 | 2,002,466.00 | 2,198,394.00 |
| 预付款项及其他应收款流动(元) | 573,780.00 | 965,644.00 | 996,900.00 | 590,698.00 | 687,933.00 | 1,038,439.00 | 1,155,976.00 | 717,629.00 |
| 存货(元) | 2,677,112.00 | 2,450,650.00 | 2,513,000.00 | 3,060,919.00 | 3,119,421.00 | 1,952,931.00 | 1,709,557.00 | 822,328.00 |
| 短期投资(元) | - | - | - | - | - | - | 10,006,758.00 | 11,997,143.00 |
| 流动资产合计(元) | 11,884,932.00 | 12,839,631.00 | 13,431,028.00 | 14,372,989.00 | 21,637,197.00 | 17,811,116.00 | 19,099,308.00 | 20,567,963.00 |
| 非流动资产： | ||||||||
| 物业、厂房及设备(元) | 33,245.00 | 38,144.00 | 43,043.00 | 45,733.00 | 48,871.00 | 53,763.00 | 74,602.00 | 94,232.00 |
| 无形资产(元) | - | - | - | - | - | 10,363,333.00 | 10,660,833.00 | 10,958,333.00 |
| 非流动资产合计(元) | 33,245.00 | 38,144.00 | 43,043.00 | 45,733.00 | 48,871.00 | 10,417,096.00 | 10,735,435.00 | 11,052,565.00 |
| 总资产(元) | 11,918,177.00 | 12,877,775.00 | 13,474,071.00 | 14,418,722.00 | 21,686,068.00 | 28,228,212.00 | 29,834,743.00 | 31,620,528.00 |
| 流动负债： | ||||||||
| 融资租赁负债流动(元) | - | - | - | - | 3,807.00 | 9,472.00 | 15,083.00 | 20,638.00 |
| 应付账款及票据(元) | 614,122.00 | 881,600.00 | 985,322.00 | 888,568.00 | 1,518,052.00 | 1,040,596.00 | 1,095,800.00 | 1,146,369.00 |
| 其他应付款及应计费用(元) | 704,912.00 | 550,057.00 | 452,504.00 | 508,730.00 | 558,287.00 | 683,158.00 | 582,311.00 | 659,401.00 |
| 衍生工具负债流动(元) | - | - | 558,700.00 | 780,700.00 | 1,931,400.00 | - | - | - |
| 流动负债合计(元) | 1,319,034.00 | 1,431,657.00 | 1,996,526.00 | 2,177,998.00 | 4,011,546.00 | 1,733,226.00 | 1,693,194.00 | 1,826,408.00 |
| 非流动负债： | ||||||||
| 衍生工具负债非流动(元) | 2,453,100.00 | 3,744,400.00 | 4,236,500.00 | 3,759,200.00 | 4,506,600.00 | - | - | - |
| 非流动负债合计(元) | 2,453,100.00 | 3,744,400.00 | 4,236,500.00 | 3,759,200.00 | 4,506,600.00 | - | - | - |
| 总负债(元) | 3,772,134.00 | 5,176,057.00 | 6,233,026.00 | 5,937,198.00 | 8,518,146.00 | 1,733,226.00 | 1,693,194.00 | 1,826,408.00 |
| 股东权益： | ||||||||
| 普通股(元) | 1,275.00 | 1,275.00 | 1,267.00 | 1,267.00 | 1,267.00 | 61,601.00 | 61,601.00 | 61,427.00 |
| 优先股(元) | - | - | - | - | 5,250,000.00 | - | - | - |
| 股本溢价(元) | 101,711,035.00 | 101,691,430.00 | 101,603,398.00 | 101,671,466.00 | 101,640,955.00 | 111,252,019.00 | 111,202,470.00 | 111,153,252.00 |
| 留存收益(元) | -93,566,267.00 | -93,990,987.00 | -94,363,620.00 | -93,191,209.00 | -93,724,300.00 | -84,818,634.00 | -83,122,522.00 | -81,420,559.00 |
| 归属于母公司股东权益(元) | 8,146,043.00 | 7,701,718.00 | 7,241,045.00 | 8,481,524.00 | 13,167,922.00 | 26,494,986.00 | 28,141,549.00 | 29,794,120.00 |
| 股东权益合计(元) | 8,146,043.00 | 7,701,718.00 | 7,241,045.00 | 8,481,524.00 | 13,167,922.00 | 26,494,986.00 | 28,141,549.00 | 29,794,120.00 |
| 负债及股东权益合计(元) | 11,918,177.00 | 12,877,775.00 | 13,474,071.00 | 14,418,722.00 | 21,686,068.00 | 28,228,212.00 | 29,834,743.00 | 31,620,528.00 |
| 公告日期 | 2024-03-29 | 2023-11-13 | 2023-08-14 | 2023-05-15 | 2023-04-17 | 2022-11-14 | 2022-08-11 | 2022-05-12 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | ||||||||
| 核数师 |